- English
- 日本語
- 한국어
- Deutsch
- Français
- Español
No data
官方服务号
招聘公众号
Acro Partnering, the innovation platform of ACROBiosystems Group, is creating an ecosystem for life science tools, reagents, and instruments. We collaborate with businesses, research institutions, and startups to commercialize technologies that are already mature or will be mature within 3-5 years. Together, we serve the ever-growing global customer base of ACROBiosystems Group, which includes pharmaceutical companies, CRO/CDMOs, research institutions, and hospitals.
ACROBiosystems Group, a biotechnology company, aims to be a cornerstone of the global biopharmaceutical and health industries by providing innovative products and business models. Active across the US, Switzerland, the UK, and Germany, with offices in over 10 cities, we have served over 9000 clients and partnered with leading pharmaceutical companies and academic institutes
Acro Partnering, the innovation platform of ACROBiosystems Group, is creating an ecosystem for life science tools, reagents, and instruments. We collaborate with businesses, research institutions, and startups to commercialize technologies that are already mature or will be mature within 3-5 years. Together, we serve the ever-growing global customer base of ACROBiosystems Group, which includes pharmaceutical companies, CRO/CDMOs, research institutions, and hospitals.
ACROBiosystems Group, a biotechnology company, aims to be a cornerstone of the global biopharmaceutical and health industries by providing innovative products and business models. Active across the US, Switzerland, the UK, and Germany, with offices in over 10 cities, we have served over 9000 clients and partnered with leading pharmaceutical companies and academic institutes
Acro Partnering, the innovation platform of ACROBiosystems Group, is creating an ecosystem for life science tools, reagents, and instruments. We collaborate with businesses, research institutions, and startups to commercialize technologies that are already mature or will be mature within 3-5 years. Together, we serve the ever-growing global customer base of ACROBiosystems Group, which includes pharmaceutical companies, CRO/CDMOs, research institutions, and hospitals.
ACROBiosystems Group, a biotechnology company, aims to be a cornerstone of the global biopharmaceutical and health industries by providing innovative products and business models. Active across the US, Switzerland, the UK, and Germany, with offices in over 10 cities, we have served over 9000 clients and partnered with leading pharmaceutical companies and academic institutes
Acro Partnering, the innovation platform of ACROBiosystems Group, is creating an ecosystem for life science tools, reagents, and instruments. We collaborate with businesses, research institutions, and startups to commercialize technologies that are already mature or will be mature within 3-5 years. Together, we serve the ever-growing global customer base of ACROBiosystems Group, which includes pharmaceutical companies, CRO/CDMOs, research institutions, and hospitals.
ACROBiosystems Group, a biotechnology company, aims to be a cornerstone of the global biopharmaceutical and health industries by providing innovative products and business models. Active across the US, Switzerland, the UK, and Germany, with offices in over 10 cities, we have served over 9000 clients and partnered with leading pharmaceutical companies and academic institutes
Acro Partnering, the innovation platform of ACROBiosystems Group, is creating an ecosystem for life science tools, reagents, and instruments. We collaborate with businesses, research institutions, and startups to commercialize technologies that are already mature or will be mature within 3-5 years. Together, we serve the ever-growing global customer base of ACROBiosystems Group, which includes pharmaceutical companies, CRO/CDMOs, research institutions, and hospitals.
ACROBiosystems Group, a biotechnology company, aims to be a cornerstone of the global biopharmaceutical and health industries by providing innovative products and business models. Active across the US, Switzerland, the UK, and Germany, with offices in over 10 cities, we have served over 9000 clients and partnered with leading pharmaceutical companies and academic institutes
Induced differentiation of cells
Gene editing technology and synthetic biology platforms
Single-cell analysis and evaluation platforms
Cell sorting and activation technology
Scalable cell production technology
Potency evaluation and CMC quality control
Medicinal compound components (Linker, Payload, etc.)
Conjugation technologies
Purification technologies and processes
Large-scale production process
Quality control and assurance systems
Phage display and high-throughput screening platforms
Expression elements and vector libraries
Cell-free protein expression systems
AI-assisted protein, antibody, and peptide design platforms
Engineered cells and strains
Optimization and modification of protein secretion systems
Inclusion body denaturation and renaturation techniques
Cell lines
Protein, antibody expression, and purification technologies
Vector design and screening strategies
Vector tools and RNA delivery platform technologies
Patent-pending gene editing systems (e.g., high-precision editing, epigenetic regulation, etc.)
Development of virus-producing cell lines
Purification technologies and processes
Large-scale production and quality control
RNA modification and detection technologies
Rare disease cell and organoid models
Optogenetics and neurostimulation platforms
iPS and other cell sample libraries
Organoid culture-related consumables and reagents
Neural-related ion channel cell lines
Electrophysiology and imaging downstream detection instruments and technologies
Behavioral analysis and microdialysis techniques
Peptide synthesis technologies (automated, high-yield conjugation)
Peptide mimetics and stable peptide synthesis technologies
Peptide design platforms and high-throughput screening systems
Induced differentiation of cells
Gene editing technology and synthetic biology platforms
Single-cell analysis and evaluation platforms
Cell sorting and activation technology
Scalable cell production technology
Potency evaluation and CMC quality control
Medicinal compound components (Linker, Payload, etc.)
Conjugation technologies
Purification technologies and processes
Large-scale production process
Quality control and assurance systems
Phage display and high-throughput screening platforms
Expression elements and vector libraries
Cell-free protein expression systems
AI-assisted protein, antibody, and peptide design platforms
Engineered cells and strains
Optimization and modification of protein secretion systems
Inclusion body denaturation and renaturation techniques
Cell lines
Protein, antibody expression, and purification technologies
Vector design and screening strategies
Vector tools and RNA delivery platform technologies
Patent-pending gene editing systems (e.g., high-precision editing, epigenetic regulation, etc.)
Development of virus-producing cell lines
Purification technologies and processes
Large-scale production and quality control
RNA modification and detection technologies
Rare disease cell and organoid models
Optogenetics and neurostimulation platforms
iPS and other cell sample libraries
Organoid culture-related consumables and reagents
Neural-related ion channel cell lines
Electrophysiology and imaging downstream detection instruments and technologies
Behavioral analysis and microdialysis techniques
Peptide synthesis technologies (automated, high-yield conjugation)
Peptide mimetics and stable peptide synthesis technologies
Peptide design platforms and high-throughput screening systems
Induced differentiation of cells
Gene editing technology and synthetic biology platforms
Single-cell analysis and evaluation platforms
Cell sorting and activation technology
Scalable cell production technology
Potency evaluation and CMC quality control
Medicinal compound components (Linker, Payload, etc.)
Conjugation technologies
Purification technologies and processes
Large-scale production process
Quality control and assurance systems
Phage display and high-throughput screening platforms
Expression elements and vector libraries
Cell-free protein expression systems
AI-assisted protein, antibody, and peptide design platforms
Engineered cells and strains
Optimization and modification of protein secretion systems
Inclusion body denaturation and renaturation techniques
Cell lines
Protein, antibody expression, and purification technologies
Vector design and screening strategies
Vector tools and RNA delivery platform technologies
Patent-pending gene editing systems (e.g., high-precision editing, epigenetic regulation, etc.)
Development of virus-producing cell lines
Purification technologies and processes
Large-scale production and quality control
RNA modification and detection technologies
Rare disease cell and organoid models
Optogenetics and neurostimulation platforms
iPS and other cell sample libraries
Organoid culture-related consumables and reagents
Neural-related ion channel cell lines
Electrophysiology and imaging downstream detection instruments and technologies
Behavioral analysis and microdialysis techniques
Peptide synthesis technologies (automated, high-yield conjugation)
Peptide mimetics and stable peptide synthesis technologies
Peptide design platforms and high-throughput screening systems
Induced differentiation of cells
Gene editing technology and synthetic biology platforms
Single-cell analysis and evaluation platforms
Cell sorting and activation technology
Scalable cell production technology
Potency evaluation and CMC quality control
Medicinal compound components (Linker, Payload, etc.)
Conjugation technologies
Purification technologies and processes
Large-scale production process
Quality control and assurance systems
Phage display and high-throughput screening platforms
Expression elements and vector libraries
Cell-free protein expression systems
AI-assisted protein, antibody, and peptide design platforms
Engineered cells and strains
Optimization and modification of protein secretion systems
Inclusion body denaturation and renaturation techniques
Cell lines
Protein, antibody expression, and purification technologies
Vector design and screening strategies
Vector tools and RNA delivery platform technologies
Patent-pending gene editing systems (e.g., high-precision editing, epigenetic regulation, etc.)
Development of virus-producing cell lines
Purification technologies and processes
Large-scale production and quality control
RNA modification and detection technologies
Rare disease cell and organoid models
Optogenetics and neurostimulation platforms
iPS and other cell sample libraries
Organoid culture-related consumables and reagents
Neural-related ion channel cell lines
Electrophysiology and imaging downstream detection instruments and technologies
Behavioral analysis and microdialysis techniques
Peptide synthesis technologies (automated, high-yield conjugation)
Peptide mimetics and stable peptide synthesis technologies
Peptide design platforms and high-throughput screening systems
积分兑换
关注公众号
